KLOW Blend
SKU PP-KLOW · 80mg total50mg GHK-Cu · 10mg BPC-157 · 10mg TB-500 · 10mg KPV
80mg four-peptide research blend: 50mg GHK-Cu, 10mg BPC-157, 10mg TB-500 and 10mg KPV in one vial.
KLOW Blend pricing (GBP)
| Strength | Pen | Refill | Vial |
|---|---|---|---|
| 80mg total In stock |
Select a price to choose that option. UK shipping £3.80 — free over £100.
What's in KLOW Blend: component breakdown
- GHK-Cu 50mg
- BPC-157 10mg
- TB-500 10mg
- KPV 10mg
| Component | Amount per vial | Share | Research profile |
|---|---|---|---|
| GHK-Cu | 50mg | 62.5% | Copper tripeptide (Gly-His-Lys·Cu). Studied for collagen, decorin and extracellular-matrix gene expression in dermal fibroblast models. |
| BPC-157 | 10mg | 12.5% | 15-residue pentadecapeptide (GEPPPGKPADDAGLV). Studied in fibroblast migration, angiogenesis and VEGFR2 signalling models. |
| TB-500 | 10mg | 12.5% | Synthetic peptide derived from the actin-binding region of thymosin β4. Studied in cell-migration, actin-dynamics and wound-closure assays. |
| KPV | 10mg | 12.5% | Tripeptide Lys-Pro-Val (C16H30N4O4, ~342.4 Da), the C-terminal fragment of α-MSH. Studied in NF-κB and inflammatory-signalling models in epithelial and keratinocyte cells. |
| Total | 80mg | 100% | Lyophilised blend in one sealed vial |
Composition is confirmed on the certificate of analysis for each batch.
About KLOW Blend
KLOW is an 80mg four-peptide research blend combining 50mg GHK-Cu, 10mg BPC-157, 10mg TB-500 and 10mg KPV in a single lyophilised vial. It brings together peptides individually studied in dermal-matrix, cell-migration and inflammatory-signalling research, so their combined effects can be investigated in one in-vitro model.
GHK-Cu makes up the majority of the blend (62.5% by mass), with BPC-157, TB-500 and KPV each contributing 12.5%. The composition of every batch is confirmed on its certificate of analysis.
Research applications
- Extracellular-matrix remodelling and collagen expression
- Fibroblast and keratinocyte migration (scratch) assays
- Inflammatory and NF-κB signalling in skin cell models
- Keratinocyte–fibroblast co-culture and barrier-function models
Mechanism studied
Combines a copper-binding matrix peptide (GHK-Cu), two cell-migration peptides (BPC-157 and TB-500) and an α-MSH-derived anti-inflammatory tripeptide (KPV), studied together in dermal and wound-model research.
Also known as: KLOW peptide blend, GHK-Cu / BPC-157 / TB-500 / KPV blend, multi-peptide research matrix.
Specifications
| Product | KLOW Blend |
|---|---|
| SKU | PP-KLOW |
| Molecular formula | Blend — GHK-Cu, BPC-157, TB-500, KPV |
| Molecular weight | See component breakdown |
| Sequence | GHK-Cu 50mg · BPC-157 10mg · TB-500 10mg · KPV 10mg |
| Strengths | 80mg total |
| Purity | ≥99% (HPLC) |
| Form | Lyophilised powder |
| Storage | −20 °C, sealed, protected from light |
| Pen | Pre-filled pen-format research presentation |
| Refill | Replacement cartridge for the pen format |
| Vial | Lyophilised powder in a sealed glass vial |
| Intended use | In-vitro laboratory research only |
KLOW Blend FAQ
What is in the KLOW blend?
Each 80mg vial contains 50mg GHK-Cu, 10mg BPC-157, 10mg TB-500 and 10mg KPV. The composition is confirmed on the batch COA.
What is KPV?
KPV is the tripeptide Lys-Pro-Val, the C-terminal fragment of alpha-melanocyte-stimulating hormone (α-MSH), studied in inflammatory-signalling research.
How much is KLOW?
£90.00 as a vial, £95.00 as a refill and £110.00 in pen format.
How much is UK shipping?
UK shipping is a flat £3.80 and free on orders over £100.
Compliance disclaimer
All Port Peptides products are supplied strictly for in-vitro laboratory research and analytical purposes. They are not intended for human consumption, medical use or veterinary use, and are not drugs, foods, supplements or cosmetics.
Product guidance: we operate exclusively as a research-material supplier and are therefore unable to provide guidance relating to human use, including dosage, administration, preparation or mixing instructions.
